Article Details

Entasis Therapeutics Introduces ETX0462, a First-in-Class Candidate, Targeting Multidrug ...

Retrieved on: 2021-07-02 12:33:45

Tags for this article:

Click the tags to see associated articles and topics

Entasis Therapeutics Introduces ETX0462, a First-in-Class Candidate, Targeting Multidrug .... View article details on hiswai:

Excerpt

(NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up